"We also have to remember that the world is changing when it comes to medicine pricing. Australia has negotiated very good deals for a long time but we are coming under increasing scrutiny," said AbbVie's Chris Stemple.
AbbVie's Chris Stemple: Australia facing increased scrutiny on pricing
January 11, 2021 Latest NewsBioPharmaDispatch ExecutiveLatest Video
New Stories
-
President's nominee denies calling for seizure of pharmaceutical patents
January 30, 2025 - - Latest News -
GPs call on NSW Government to fund free Meningococcal B vaccine
January 30, 2025 - - Latest News -
New Zealand's Pharmac reconsiders proposed move to single oestradiol patch brand
January 30, 2025 - - Latest News -
QBiotics strengthens medical leadership with two senior appointments
January 28, 2025 - - Australian Biotech -
Chemist Warehouse reports strong sales and earnings growth with merger to progress
January 28, 2025 - - Latest News -
Trapped arguing for changes that won't make a meaningful difference
January 28, 2025 - - Latest News -
Medicines Australia wants progress on 'immediate impact' recommendations
January 28, 2025 - - Latest News